STAT March 26, 2025
Using data from past trials, Altis Labs showed superior survival prediction in lung cancer patients
When AstraZeneca announced the results of its failed lung cancer immunotherapy trial in 2017, its stock plunged 16%. But that data was good for something — today, the drugmaker presented a re-evaluation of data from...